PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Relaxed blood pressure guidelines cut millions from needing medication

2014-03-29
(Press-News.org) DURHAM, N.C. – New guidelines that ease the recommended blood pressure could result in 5.8 million U.S. adults no longer needing hypertension medication, according to an analysis by Duke Medicine researchers.

The findings are the first peer-reviewed analysis to quantify the impact of guidelines announced in February by the Eighth Joint National Committee. In a divisive move, the committee relaxed the blood pressure goal in adults 60 years and older to 150/90, instead of the previous goal of 140/90.

Blood pressure goals were also eased for adults with diabetes and kidney disease.

"Raising the target in older adults is controversial, and not all experts agree with this new recommendation," said lead author Ann Marie Navar-Boggan, a cardiology fellow at Duke University School of Medicine. "In this study, we wanted to determine the number of adults affected by these changes."

Researchers at the Duke Clinical Research Institute, in collaboration with McGill University, published their results online March 29, 2014, in the Journal of the American Medical Association, to coincide with the American College of Cardiology meeting in Washington, D.C.

Researchers used 2005-2010 data from the National Health and Nutrition Examination Survey (NHANES) conducted by the Centers for Disease Control and Prevention. The database included more than 16,000 participants with blood pressure measurements.

Based on the study sample, the researchers determined that the proportion of U.S. adults considered eligible for hypertension treatment would decrease from 40.6 percent under the old guidelines to 31.7 percent under the new recommendations.

In addition, 13.5 million adults - most of them over the age of 60 - would no longer be classified in a danger zone of poorly controlled blood pressure, and instead would be considered adequately managed. This includes 5.8 million U.S. adults who would no longer need blood pressure pills if the guidelines were rigidly applied.

"The new guidelines do not address whether these adults should still be considered as having hypertension," Navar-Boggan said. "But they would no longer need medication to lower their blood pressure."

According to the study, one in four adults over the age of 60 is currently being treated for high blood pressure and meeting the stricter targets set by previous guidelines.

"These adults would be eligible for less intensive blood pressure medication under the new guidelines, particularly if they were experiencing side effects," Navar-Boggan said. "But many experts fear that increasing blood pressure levels in these adults could be harmful."

"This study reinforces how many Americans with hypertension fall into the treatment 'gray zone' where we don't know how aggressive to treat and where we urgently need to conduct more research" said Eric D. Peterson, M.D., professor of medicine and director of DCRI.

Navar-Boggan said that even under the newer, less stringent guidelines, an estimated 28 million U.S. adults with hypertension still have uncontrolled blood pressure, and over half of them remain untreated.

"Uncontrolled hypertension is a huge missed opportunity for prevention of cardiovascular diseases such as stroke and heart attack," Navar-Boggan said.

INFORMATION: In addition to Navar-Boggan and Peterson, study authors include Michael J. Pencina of Duke, Ken Williams of KenAnCo Biostatistics and Allan D. Sniderman of McGill University.

The DCRI funded the study, along with grants from M. Jean de Granpre and Louis & Sylvia Vogel.


ELSE PRESS RELEASES FROM THIS DATE:

Study estimates proportion of adults affected by new blood pressure guideline

2014-03-29
Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that an estimated 13.5 million adults would now be considered as having achieved goal blood pressure, primarily older adults, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions. Ann Marie Navar-Boggan, M.D., Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues quantified the proportion of adults potentially ...

US, European cholesterol guidelines differ in statin use recommendations

2014-03-29
Application of U.S. and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially, with one U.S. guideline recommending statins for nearly all men and two-thirds of women, proportions exceeding those of the other guidelines, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions. The common approach in cardiovascular disease (CVD) primary prevention is to identify individuals at high enough risk to justify more intensive lifestyle ...

Analysis supports use of risk equations to guide statin therapy

2014-03-29
In an analysis of almost 11,000 patients, an assessment of equations that help guide whether a patient should begin taking a statin (cholesterol lowering medication) found that observed and predicted 5-year atherosclerotic cardiovascular disease risks were similar, suggesting that these equations are helpful for clinical decision making, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published ...

Celiac disease linked to increased risk of coronary artery disease

2014-03-29
People with celiac disease may have a near two-fold increased risk of coronary artery disease compared with the general population, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. The study is the first to look at the association between celiac disease and coronary artery disease and adds to the evolving understanding of how systemic inflammation and autoimmune processes might influence cardiovascular disease development. Data also showed a slightly higher risk of stroke among people with celiac disease compared ...

Are statins good for your love life?

2014-03-29
Statins are associated with a significant improvement in erectile function, a fact researchers hope will encourage men who need statins to reduce their risk of heart attack to take them, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. Erectile dysfunction is common in older men, especially among those with cardiovascular risk factors where cholesterol-lowering statins are frequently prescribed. Previous research has suggested a negative association between statin therapy and testosterone levels, leading to ...

Study finds astronauts' hearts become more spherical in space

2014-03-29
New findings from a study of 12 astronauts show the heart becomes more spherical when exposed to long periods of microgravity in space, a change that could lead to cardiac problems, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. With implications for an eventual manned mission to Mars, the findings represent an important step toward understanding how a spaceflight of 18 months or more could affect astronauts' heart health. "The heart doesn't work as hard in space, which can cause a loss of muscle mass," ...

Daylight saving impacts the timing of heart attacks

2014-03-29
Still feeling the residual effects of springing ahead for daylight saving time? The hour of sleep lost – or gained – may play a bigger, perhaps more dangerous role in our body's natural rhythm than we think. It seems moving the clock forward or backward may alter the timing of when heart attacks occur in the week following these time changes, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. Data from the largest study of its kind in the U.S. reveal a 25 percent jump in the number of heart attacks occurring the ...

Too many diet drinks may spell heart trouble for older women

2014-03-29
It appears healthy postmenopausal women who drink two or more diet drinks a day may be more likely to have a heart attack, stroke or other cardiovascular problems, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. In fact, compared to women who never or only rarely consume diet drinks, those who consumed two or more a day were 30 percent more likely to suffer a cardiovascular event and 50 percent more likely to die from related disease. Researchers analyzed diet drink intake and cardiovascular risk factors from ...

New approach to leukemia testing may better define prognosis, treatment

New approach to leukemia testing may better define prognosis, treatment
2014-03-29
Augusta, Ga. – Nearly half of patients with the most common form of adult leukemia are said to have normal chromosomes but appear instead to have a distinct pattern of genetic abnormalities that could better define their prognosis and treatment, researchers report. Using microarray technology that probes millions of genes within chromosomes, researchers found the unique pattern in the leukemia cells of 22 patients diagnosed with cytogenetically normal acute myelogenous leukemia, said Dr. Ravindra Kolhe, molecular pathologist at the Medical College of Georgia at Georgia ...

Commonly used intra-aortic balloon pump may have broader potential for heart patients

Commonly used intra-aortic balloon pump may have broader potential for heart patients
2014-03-29
Augusta, Ga. – The most frequently used mechanical circulatory assist device in the world may have untapped potential, physicians say. One of many uses for the intra-aortic balloon pump is helping ensure adequate oxygen and blood delivery to a heart struggling to resume beating in the aftermath of coronary bypass surgery, said Dr. Mary Arthur, cardiovascular anesthesiologist at the Medical College of Georgia and Georgia Regents Health System. However physicians have been advised not to use the balloon pump if heart surgery patients also have aortic insufficiency. That's ...

LAST 30 PRESS RELEASES:

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

[Press-News.org] Relaxed blood pressure guidelines cut millions from needing medication